FDA's Role In Genetic Test Reports Debated At Public Meeting
This article was originally published in The Gray Sheet
An FDA meeting drew a variety of perspectives on the formatting of genetic test results, with participants trying to balance patient safety with their right to know. One popular suggestion at the gathering was the use of tiered reports, where test results and information could be segmented based on target audience or amount of supporting evidence.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.